Harnessing pharmaceutical innovation for anti-cancer drugs: Some findings from the Italian regions

Federico Vola, Bruna Vinci, Davide Golinelli, Maria Pia Fantini and Milena Vainieri

Health Policy, 2020, vol. 124, issue 12, 1317-1324

Abstract: Governing the provision of innovative drugs is unanimously recognized as a key factor in steering the future of health care systems, by jointly affecting health outcomes and financial sustainability.

Keywords: Pharmaceuticals governance; Innovation governance; Pharmaceuticals governance tools (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851020301986
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:124:y:2020:i:12:p:1317-1324

DOI: 10.1016/j.healthpol.2020.07.016

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().